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Abstract The hypothesis that a developmental compo-
nent plays a role in subsequent disease initially arose from
epidemiological studies relating birth size to both risk
factors for cardiovascular disease and actual cardiovascular
disease prevalence in later life. The findings that small size
at birth is associated with an increased risk of cardiovas-
cular disease have led to concerns about the effect size and
the causality of the associations. However, recent studies
have overcome most methodological flaws and suggested
small effect sizes for these associations for the individual,
but an potential important effect size on a population level.
Various mechanisms underlying these associations have
been hypothesized, including fetal undernutrition, genetic
susceptibility and postnatal accelerated growth. The spe-
cific adverse exposures in fetal and early postnatal life
leading to cardiovascular disease in adult life are not yet
fully understood. Current studies suggest that both envi-
ronmental and genetic factors in various periods of life may
underlie the complex associations of fetal growth retarda-
tion and low birth weight with cardiovascular disease in
later life. To estimate the population effect size and to
identify the underlying mechanisms, well-designed epide-
miological studies are needed. This review is focused on
specific adverse fetal exposures, cardiovascular adaptations
and perspectives for new studies.
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disease  Fetal origins  Epidemiology  Follow-up
Introduction
Many epidemiological studies from different geographical
regions demonstrated consistent association between low
birth weight and the risk of cardiovascular disease [1–3].
These associations can not be explained by preterm birth [4,
5]. Also, they seem to be independent of influences in adult
life including social class, obesity and smoking habits [6, 7].
The mechanisms underlying these associations are not well
known. It has been suggested that developmental adapta-
tions due to suboptimal fetal nutrition permanently program
the fetus and lead to an increased risk of coronary heart
disease many decades later [8]. It has also been argued that
the associations between size at birth and later disease could
primarily be the result from common genetic influences.
Based on more recent studies, a more general developmental
plasticity hypothesis has been proposed [9]. Developmental
plasticity is defined as the ability of an organism to develop
in various ways, depending on the particular environment or
setting [10]. In this process, early environmental influences
induces anatomical, physiological and biochemical adap-
tations in later life. These adaptations may be beneficial for
short term survival but could have adverse long term con-
sequences. This latter conceptual basis is extended with the
Predictive Adaptive Response (PAR) theory, stating that
long-term consequences of these early environmental
influences may be especially harmful if the actual postnatal,
mature, environment differs from the environment predicted
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during the plastic, developmental, phase [11]. The greater
the degree of mismatch, the greater the disturbance in
physiology and the greater the risk of disease.
Studies in humans generally use birth weight as measure
of adverse fetal exposure. Birth weight might indeed be an
indicator of the quality of the intra-uterine environment
[12]. However, the same birth weight might be the result of
different growth patterns and exposures in fetal life. Fur-
thermore, a period of compensatory growth will follow
after nutritional deficit in utero. The most rapid growth
acceleration in low birth weight children occurs in the first
weeks after birth [13]. This accelerated growth rate might
also have important consequences later in life [14]. These
findings suggest that children with both restricted fetal and
infant growth and accelerated childhood weight gain are at
particular risk of cardiovascular disease in adult life and its
risk factors [15, 16].
In this paper, we discuss epidemiological studies
designed to identify mechanisms underlying the associa-
tions of fetal growth retardation and low birth weight with
the development of cardiovascular disease in adulthood.
We will focus on specific adverse fetal exposures, cardio-
vascular adaptations and perspectives for new studies.
Specific fetal exposures
Fetal undernutrition
Maternal anthropometrics, maternal diet and placenta
function
The fetal nutrition supply line includes maternal anthro-
pometrics, diet and placenta function. Maternal anthropo-
metrics during pregnancy are related to their nutritional and
health status [17, 18]. Several studies have shown that
maternal anthropometric factors such as prepregnancy
body mass index and weight gain during pregnancy are
associated with fetal growth characteristics and adverse
pregnancy outcomes [19–21]. Thus, the maternal nutri-
tional and health status during pregnancy may lead to an
adverse fetal environment and might affect fetal growth
and development (Table 1).
Studies examining the direct effect of maternal anthro-
pometrics on cardiovascular outcomes in the offspring
demonstrated conflicting results (Table 1). Most of these
studies were based on retrospective cohorts. We found in a
prospective cohort study that maternal weight gain during
pregnancy is associated with larger left ventricular mass at
the age of 6 months, independent of maternal weight just
before pregnancy [22]. Additionally, a recent study showed
that greater maternal gestational weight gain is associated
with greater offspring body mass index into early adulthood
and that this may translate into higher systolic blood pres-
sure in the offspring [23]. Several underlying biological
pathways may explain the associations between maternal
anthropometrics during pregnancy and vascular develop-
ment and cardiac growth and development postnatally.
One explanation could be that the usual increase in insulin
resistance seen in late pregnancy is higher in mothers who
show a marked increase in weight during pregnancy, result-
ing in increased fetal body and cardiac growth [24, 25].
Further studies, in which measures of insulin resistance such
as insulin, glucose or HbA1c levels in pregnancy have been
measured, are needed to identify the potential role of insulin
resistance for fetal cardiovascular development. The major
limitation of weight gain is that the total amount depends on
both an increase in fluid and fat mass. Also, it is not clear
whether maternal pre-pregnancy weight or weight gain
during pregnancy affects cardiovascular development in
the offspring.
The fetal nutrition supply line may also be directly
affected by dietary intake of the mother during pregnancy.
Follow-up of persons who were conceived during the
Dutch famine during the second World War demonstrated
a doubled risk and an earlier onset of coronary artery dis-
ease among subjects who were exposed to famine during
fetal life [16]. These results were independent of size at
birth and current smoking and social economic status and
suggest that severe maternal malnutrition during early
gestation contributes to the occurrence of coronary artery
disease in the offspring. However, these results could not
be replicated in a cohort of adults who were exposed as
fetus to severe famine during the siege of Leningrad [26].
The associations of less extreme variations in maternal
intake of macronutrients and micronutrients with the
Table 1 Maternal anthropometrics and diet in association with
cardiovascular disease later in life
Maternal anthropometric
characteristic during
pregnancy
Cardiovascular outcome
Maternal anthropometric
Short stature Increased death rates from
coronary heart disease
Low triceps skin fold thickness Increased blood pressure
High weight gain during
pregnancy
Increased left ventricular mass
Maternal diet
Total energy intake Increased risk and earlier
onset coronary artery disease
Low protein intake Increased blood pressure
Low calcium intake Increased blood pressure
Low folate intake Endothelial dysfunction
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development of risk factors for cardiovascular disease in
the offspring have also been studied. Prospective cohort
studies showed that variation in maternal total protein
intake during pregnancy does not program offspring blood
pressure already in infancy or in adolescence [27–29].
Stronger relations have been reported between micro-
nutrients and risk factors for cardiovascular disease in the
offspring. Maternal calcium supplementation during preg-
nancy has been described to be associated with lower
systolic blood pressure in the offspring [30–32]. Although,
in some follow-up studies the effect disappeared later in
childhood and no association were reported in twins [33,
34]. Therefore, it is still unclear whether ensuring adequate
calcium intake among pregnant women could be a way to
prevent hypertension in the next generation. Low folate and
high homocystein levels, in combination or independently,
have been shown to be risk factors for endothelial dys-
function and cardiovascular disease [35, 36]. In healthy
infants, a relationship between maternal folate levels dur-
ing pregnancy and vascular endothelial function was
demonstrated [37]. More recently developed statistical
approaches, such as dietary patterns of maternal nutrition
intake during pregnancy, may give more detailed inside in
the development of risk factors for cardiovascular disease
later in life.
Placental function, including placental weight and hae-
modynamic function is one of the most important deter-
minants of the fetal supply line. Size of the placenta reflects
only an indirect measure of its capacity to transfer nutrients
to the fetus, but it is strongly associated with fetal size at
birth [38]. A review focused on the associations of pla-
cental weight with the risk of cardiovascular disease in the
offspring and reported no consistent associations [39]. Pre-
eclampsia is considered as the most extreme form of hae-
modynamic placental dysfunction. According to recent
studies, women with prior preeclamptic pregnancies are at
increased risk of cardiovascular disease [40, 41]. Further-
more, preeclampsia has been associated with elevated
blood pressure in offspring during childhood and adoles-
cence [42]. Fetal growth restriction due to placental dys-
function or common genetic variants may at least partly
explain these associations. A milder form of placental
haemodynamic dysfunction is reflected by the resistance in
the umbilical artery. An increased umbilical artery resis-
tance is associated with fetal growth restriction and low
birth weight [43].
Maternal smoking during pregnancy
Maternal smoking during pregnancy is strongly associated
with fetal growth retardation [44–46]. The effects of
smoking on placental vessels could be due to nicotine or
hypoxia. This association is partly mediated by restricted
blood flow in the vascular beds of the placenta, due to
increased resistance of the umbilical-placental circulation
[47, 48]. Fetal exposure to maternal smoking might also
have adverse and persistent consequences for cardiovas-
cular growth and development. Recent studies showed
associations between intra-uterine exposure to maternal
smoking and high blood pressure in childhood and adult-
hood [49, 50]. However, the association of maternal
smoking and offspring blood pressure might be confounded
by a comprehensive range of indicators of social economic
position. Confounding by social and familial factors is
further supported by the similarity of maternal and paternal
smoking effects, suggesting that modest differences in
childhood blood pressure associated with maternal smok-
ing could be the result of not only biological effects on the
intrauterine environment, but also common adverse
familial factors [51]. Studies focused on fetal cardiovas-
cular development may unravel these associations. We
found in a prospective cohort study that maternal smoking
during pregnancy is associated with placental and fetal
haemodynamic adaptations indicating increased arterial
resistance [52]. These fetal haemodynamic adaptations
were subsequently associated with fetal growth retardation
and changes in postnatal cardiac structures. Similarly,
maternal smoking in pregnancy has also been suggested to
be directly associated with changes in fetal cardiac
dimensions and volumes [53, 54].
Genetic susceptibility
The association of fetal growth restriction and low birth
weight with the increased risk of cardiovascular disease
may also be explained by common genetic variants related
to insulin sensitivity or angiogenesis (Table 2) [55]. Insulin
and insulin-like growth factors are important fetal growth
factors [56]. Genetic factors related to insulin or insulin-
like growth factors production and sensitivity may lead to
both impaired fetal growth and to type 2 diabetes and
cardiovascular disease in later life [55]. Previously, Single
Nucleotide Polymorphisms (SNPs) in the IGF1 gene and
the INS VNTR gene have been suggested to be associated
with fetal and postnatal growth. However, these effects
seem not to be consistent [57, 58].
Common polymorphisms of type 2 diabetes gene
PPARc2 may also explain previously suggested associa-
tions of growth in early life with the risk of cardiovascular
disease in later life. Two large birth cohort studies found no
association between the PPARc2 polymorphism and birth
weight [59, 60]. We recently showed that the PPARc2
Ala12 allele is associated with an increased growth rate in
early life. This effect was modified by the duration of
breastfeeding [61]. In addition to the PPARc2 polymor-
phism, other common type 2 diabetes genetic susceptibility
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variants seem to affect size at birth directly through the
fetal genotype. Risk alleles at CDKAL1 and HHEX-IDE
were both associated with reduced birth weight. These
findings suggest the associations between low birth weight
and type 2 diabetes might at least partly explained by
common genetic variants [62]. Furthermore, it has been
demonstrated that the PPARc2 polymorphism modifies the
associations of low birth weight with lipid levels and
hypertension [63, 64].
Glucocorticoids are important regulators of cardiovas-
cular function and metabolism. Studies in rats showed
that activity of placental 11b-hydroxysteroid dehydroge-
nase type 2, which converts physiological glucocorticoids
to inactive products, correlates positively with birth
weight and negatively with placental weight [65]. In
addition, administration of low-dose dexamethasone to
pregnant rats not only reduces birth weight but also leads
to high blood pressure in young adult offspring [65]. In
human studies, it is demonstrated that fetuses with the
greatest exposure to maternal glucocorticoids have low
birth weight and high placental weight and might be at a
higher risk of subsequent hypertension [66]. Increased
exposure to cortisol in adults leads to increased risks of
cardiovascular disease, type 2 diabetes and obesity [9,
67]. Thus higher exposure to glucocorticoids in fetal and
early postnatal life might affect cardiovascular develop-
ment in fetal life and early childhood. The effects of these
hormones, including cortisol, are mediated by glucocor-
ticoid receptors. Glucocorticoid receptor gene (NR3C1)
SNPs may explain part of the associations between
growth characteristics in early life and disease in adult-
hood by increasing glucocorticoid sensitivity in the fetus
for maternal glucocorticoids. A previous study in adults
found an association between the GR-9b polymorphism
and an increased risk of cardiovascular disease [68]. We
found an association of this GR-9b polymorphism with
increased left ventricular mass and systolic blood pressure
in children aged 2 years [52]. No associations were
observed between this GR-9b polymorphism and fetal and
early postnatal growth [69]. Other recent identified glu-
cocorticoid related polymorphisms, such as the brain-
derived neurotrophic factor (BDNF) and the mineral
corticoid gene, may affect fetal and postnatal growth by
influencing the glucocorticoid metabolism.
Thus fare, results of studies focused on the associations
of common genetic variants related to both early growth
and the risk of cardiovascular disease later in life are
inconsistent. Further systematic searches for common
genetic variants by means of genome-wide association
studies will enable us to obtain a more complete under-
standing of what genes and polymorphisms are involved in
both growth in fetal life and infancy and development of
cardiovascular disease in adulthood.T
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Cardiovascular adaptations
Cardiac development
Stimuli for cardiac development
It has been demonstrated that fetuses have stiffer fetal
ventricles than neonates and the diastolic filling patterns in
normally grown fetuses mimic those of the diseased adult
heart [70]. Left ventricular elastic compliance increases
with gestational age and left ventricular stiffness signifi-
cantly decreases. In growth restricted fetuses, this process
may be affected [70]. Furthermore, reduced end-diastolic
flow velocities in fetal umbilical and maternal uteropla-
cental arteries have been associated with increased periph-
eral vascular resistance [71]. This increase in peripheral
arterial resistance and subsequently in fetal cardiac afterload
may lead to an increase in fetal cardiac performance and to
persistent structural left ventricular changes [72]. Decreased
fetal growth was also associated with fetal adaptations in
cardiac function in the whole range of fetal growth [73].
Furthermore, birth weight and measures of placental vas-
cular resistance and fetal cardiac output were associated
with left cardiac structures until the age of 2 years [74]. This
is in line with a previous prospective cohort study in chil-
dren which demonstrated positive associations of birth
weight with total coronary artery diameter, aortic root
diameter and left ventricular outflow tract diameter in
children aged 9 years [75]. However, inverse associations
between birth weight and left ventricular mass in adoles-
cents and adults have been demonstrated [76, 77]. It should
be investigated whether these relations persist during later
life and are related to the development of cardiovascular
disease in adulthood.
Adverse cardiac adaptations
Studies in children showed that left ventricular mass tracks
from childhood to adulthood [78, 79]. This implies that
children with smaller left cardiac structures in early post-
natal life tend to keep their relatively smaller left cardiac
structures in childhood [74, 78, 79]. However, a relatively
smaller left ventricle and aortic root may lead to insuffi-
cient cardiac functioning for increasing metabolic demands
in postnatal life. Subsequently, the heart may respond by
growth and adverse remodeling. Since the number of heart
cells is established largely in fetal life, adaptation and
growth of existing cells may eventually lead to left ven-
tricular dysfunction and hypertrophy. Left ventricular
hypertrophy is a strong and independent risk factor of
cardiovascular morbidity and mortality in adulthood [80,
81]. Thus fetal exposures affecting cardiac development
may have life long consequences.
Renal development
Stimuli for renal development
Nephrons start to form from day 30 of gestation [82].
Numerous factors, including the renin-angiotensin system
(RAS), various growth factors, apoptosis and an adequate
supply of nutrients are required for nephrogenesis [83–85].
Nephrogenesis continues until 36 weeks of gestation and
the induction of nephron number ceases thereafter [86, 87].
On average ±750,000 nephrons per kidney are present,
with a wide interindividual range (250,000–2,000,000)
[87–90].
Animal studies have shown that various determinants of
fetal nutrition including low protein intake, relative vitamin
A deficiency, reduced placenta perfusion and administra-
tion of steroids in late pregnancy cause fetal growth
restriction, smaller kidneys and a permanent reduced
nephron number [91–94]. Human studies demonstrated that
low birth weight infants have lower kidney weight with a
reduced number of nephrons [95, 96]. It was also demon-
strated that hypertensive subjects have lower nephron
numbers [90]. The best surrogate measure for assessing
nephron number in epidemiological studies appears to be
kidney weight or size measured by ultrasound [87]. A few
studies investigated renal length or volume in early life.
Being small for gestational age (SGA) is associated with
small kidneys at birth and impaired kidney growth in early
childhood [97]. Kidney length in preterm SGA infants
follows closely the other anthropometric parameters during
the first year of life [98]. SGA term infants had shorter
kidney length at birth compared to appropriate for gesta-
tional age infants, but a similar length from 3rd to 24th
month of life [99]. This may represent either an accelerated
renal maturation or early compensatory kidney hypertro-
phy in the SGA infants. Maternal anthropometrics, fetal
abdominal circumference, fetal blood flow redistribution,
and raised placental resistance are associated with both
third trimester fetal kidney volume and kidney volume at
the age of 2 years [100, 101]. Since, kidney size tracks
from third trimester of pregnancy to early childhood, these
adaptations may have persistent consequences [100].
Adverse renal adaptations
The kidneys respond to this reduced number of nephrons
by hyperperfusion and remodelling [102]. According to the
hyperfiltration theory, this will lead to more sodium reab-
sorption, increased systolic blood pressure and albuminuria
[103]. This process may be in favor of short-term renal
function but may eventually lead to glomerular hypertro-
phy and damage [102]. Finally, this may predispose the
individual to renal failure and hypertension. It has been
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shown that low birth weight is associated with early onset
chronic renal failure. In subjects aged less than 50 years,
those who weighted less than 2.5 kg at birth had a higher
risk for end-stage renal disease than people who weighted
3–3.5 kg at birth [104]. This association was shown in all
groups of primary causes of end stage renal failure in adults
(hypertension, diabetes and other causes). Studies in
younger subjects have focused on urine albumin excretion,
a predictor of cardiovascular and renal disease in diabetic
and non-diabetic subjects [105]. Low birth weight is
associated with microalbuminuria in children and adults
independent of blood pressure and measures of insulin
resistance [106, 107]. The pathway leading from small
kidneys to hypertension may include the renin-angiotensin
system, which has been demonstrated to be altered in the
early phase of primary hypertension [108]. An increased
activity of the renin-angiotensin system could be a com-
pensatory mechanism in a decreased number of nephrons
in order to maintain normal renal filtration. It has
been demonstrated that renin activity in umbilical cord
blood is inversely related with the size of the kidney at
birth [109].
Vascular development
Haemodynamic stimuli for fetal vascular development
Fetal growth retardation leads to a preferential blood flow
to the brain and heart, which deprives other organs of
adequate oxygen and nutrients supply. This brain-sparing
suggests organ specific vasodilatation and vasoconstric-
tion and has been demonstrated in growth restricted
fetuses [110]. In addition, we recently demonstrated that
decreased fetal growth is associated with adaptive fetal
cardiovascular changes [73]. These changes already
occured before the onset of clinically apparent fetal
growth restriction. Future studies are needed to identify
whether these adaptations in fetal haemodynamics have
consequences for the development of cardiovascular dis-
ease in later life.
Endothelial function
The endothelium controls vascular tone, coagulation and
inflammatory responses [111]. Endothelial dysfunction is
an early event of atherosclerosis, preceding structural
changes in the vascular wall [112]. Atherosclerosis is
thought to begin in childhood and to develop silently
before clinical events such as myocardial infarction or
stroke occur. Many studies demonstrated atherosclerotic
wall thickening in the arteries of children with cardiovas-
cular risk factors using ultrasound imaging [113]. Fur-
thermore, studies have shown that risk factors for
cardiovascular disease measured in childhood are track into
adulthood [114, 115]. There is limited direct evidence that
risk factors measured in childhood are predictive of ath-
erosclerosis in adulthood [116, 117]. Only a few studies
examined the associations of fetal and maternal factors
during pregnancy and vascular changes in childhood. Low
maternal folate levels during pregnancy and low birth
weight are demonstrated to be associated with vascular
endothelial dysfunction in newborn infants [37, 118, 119].
Further follow up studies are needed.
Arterial stiffness
Flow may determine vascular growth in the fetal cardio-
vascular system and thereby a reduction in flow may alter
later vascular behaviour [120]. One mechanism that could
underlie the association of low birth weight with raised
blood pressure may be a suboptimal development of the
fetal cardiovascular system due to these circulatory chan-
ges, thus increasing the stiffness of the vessel wall and
comprising the cardiovascular function [121]. Several
studies have attempted to test this hypothesis by investi-
gating the relationship between birth weight and indicators
of arterial stiffness such as pulse wave velocity and pulse
pressure, but with conflicting results [122–125]. Another
mechanism could be that these haemodynamic adaptive
changes in the fetal circulation, which occur in a critical
period of blood vessel development, may influence rates of
elastin synthesis [125]. This may result in a reduced
compliance of the large arteries, leading to higher pulse
and mean blood pressures. Furthermore, the process of
aging causes a gradual loss of elastin and replacement by
collagen, which amplifies the increase in blood pressure
[125]. Persistent alteration in conduit artery function and
arterial stiffness may predispose a person to hypertension
and cardiovascular disease in adulthood.
Perspectives
Study designs
The associations of fetal growth retardation and low birth
weight with cardiovascular disease are not yet fully under-
stood. Methodological issues, such as the role of potential
confounders in the associations and the population effect
size, should be further examined. Well-designed epidemi-
ological studies are necessary to overcome current meth-
odological issues. Population-based prospective cohort
studies starting in the preconceptional period or in early fetal
life, in which the offspring is followed from early fetal life
until young adulthood, seem to be the most suitable
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epidemiological design (Fig. 1). This epidemiological
design is the best design for assuring quality of the data,
taking account for potential confounders and identifying
growth patterns at risk. Recently, various population-based
prospective cohort studies have been started worldwide
[126–129]. However, a limitation of this design is the long
period needed for the studied adult disease to develop. The
design of a retrospective cohort study may lead to an earlier
availability of data according to cardiovascular disease.
However, this design will not take account of all potential
confounders and will probably not be able to study the
effects of fetal or early postnatal influences.
The effects of many adverse fetal exposures due to
maternal life style habits can only be studied in observa-
tional designs. However, for assessing the effects of
nutritional exposures on fetal growth restriction and the
risk of cardiovascular disease, randomized controlled trials
would be the design of choice. For example the impact of
calcium, folate and other micronutrients on offspring birth
weight and blood pressure is examined in randomized
controlled trials [30, 32, 130]. Randomized controlled trials
should be able to overcome current methodological issues
and identify mechanisms in the causal pathway that
underlie the associations.
Detailed exposure studies
Nutrition
In Western countries, maternal variation in dietary patterns
and intake of micronutrients seems more relevant than a
restricted total energy and macronutrient intake for having an
effect on fetal growth retardation [131]. Future studies
should focus on the intake of particular macronutrients and
micronutrients, including calcium, folic acid and homocy-
stein, in specific periods of pregnancy. Identifying critical
periods in pregnancy will result in detailed dietary advices
aimed at these specific time points in pregnancy. Addition-
ally, dietary patterns during the preconception period have
been associated with biomarkers concentrations and related
to complex diseases, such as cardiovascular disease [132,
133]. Overall dietary patterns may be easier for the public to
interpret or translate into diets.
Genome-wide association studies
Common genetic variants may explain the associations
between growth in early life and diseases in adulthood.
Child
•Nutrition
•Passive smoke exposure
Fetal and placental growth and 
birth weight Childhood growth
Cardiovascular developmental changes
Vascular adaptations
•Arterial stiffness
•Endothelial dysfunction
•Microvascular structures
Renal adaptations
•Kidney volume
•Renal function
•RAAS programming
Cardiac  adaptations
•Left ventricular growth
•Aortic root diameter
Risk factors adult 
cardiovascular disease 
in childhood
•Blood pressure
•Arterial stiffness
•Atherosclerosis
•Coronary heart disease
Mother and Father
•Anthropometrics and diet
•Smoking habits
•Genetic susceptibility Risk factors for adult 
cardiovascular disease
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D
evelopm
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G
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Fig. 1 A developmental origins study model, studying the fetal
origins of cardiovascular disease in epidemiological studies. This
model presents core associations that have to be studied to unravel the
underlying mechanisms of the associations of fetal growth restriction
and low birth weight and cardiovascular disease later in life. The
upper part shows associations in mother and father, identifying both
determinants of fetal and postnatal growth patterns and environmental
and genetic mechanisms. The lower part demonstrates associations in
the offspring that have to identify growth patterns and developmental
changes in fetal and early postnatal life, resulting in an increased risk
of cardiovascular disease in adulthood. RAAS Renin-angiotensin-
aldosterone system
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Large scale genome-wide association studies (GWAS)
have revealed links between DNA sequence variation and a
growing range of diseases and continuous traits, such as
cardiovascular disease and type 2 diabetes [134–136]. The
effect of these common genetic variants on growth char-
acteristics and growth patterns may already be present in
fetal and early postnatal life. Relating these genetic loci to
early growth patterns might identify genes related to both
fetal growth retardation and cardiovascular disease.
Epigenetics
Epigenetics is understood as the heritable changes in gene
expression potential that are not caused by changes in DNA
sequence [137, 138]. DNA methylation is one of the best
understood epigenetic modification and is a key epigenetic
contributor to maintenance of gene silencing. CpG islands
are mostly located in the control regions of genes, for
example the promoter region of actively transcribed gene,
and are generally unmethylated. Methylation of this pro-
moter region leads to decreased binding of transcription
factors and thereby to a reduced gene expression [139].
Maternal diet has been shown to dynamically affect DNA
methylation status [140]. Methyl-supplemented diets
include the methyl donors such as folic acid, vitamin B12,
choline, L-methionine and zinc. Studies in sheep showed
associations between reductions in the availability of Vita-
min B12 and folate during the periconceptual period and
alterations in methylation status of CpG islands in the off-
spring [141]. This may lead to widespread epigenetic mod-
ifications to the genome of the offspring. In humans, lower
DNA methylation of the IGF2 gene was reported in adults
who have been exposed to the Dutch Famine in the per-
iconceptional period [142]. These results suggest that early-
life environmental conditions can cause epigenetic changes
that persist throughout life and could lead to the development
of risk factors for hypertension and cardiovascular disease in
adult offspring. However, future research is needed to better
understand the role of epigenetic dysregulation in the asso-
ciations between adverse fetal nutritional exposures and
diseases in adult life [143]. Since the periconceptional period
is a crucial period for establishing and maintaining epige-
netic marks, cohort studies starting in the preconceptional
period would give important knowledge [144].
Paternal influences
We discussed substantial affects on fetal programming by
maternal prenatal behaviors, specifically by maternal
smoking, maternal diet and maternal genetic susceptibility.
However, paternal influences, for example paternal genetic
susceptibility, could also underlie the pathways of fetal
growth retardation and low birth weight to the development
of cardiovascular disease in adulthood. Also, comparing
maternal and paternal effects provides a method of sepa-
rating intra-uterine effects from associations related to
familial or environmental factors. Similar associations of
maternal and paternal exposures with offspring health out-
comes suggest that common factors related to the family or
environment may drive the associations, rather than intra-
uterine effects only. Future research is required to compare
associations of both maternal and paternal exposures during
pregnancy with components of offspring health.
Detailed cardiovascular development studies
To disentangle the mechanisms underlying the associations
of fetal growth restriction and low birth weight with the
development of cardiovascular disease, future research
should focus on early markers of cardiovascular adaptation.
Good repeatability and reproducibility of most left cardiac
structures in children measured by 2D ultrasound is previ-
ously demonstrated in large-scale multicenter studies in
young children [145, 146]. However, newer imaging tech-
niques, such as three-dimensional echocardiography and
magnetic resonance imaging, can more precisely calculate
physiologic variables of interest [147]. In the future, these
new imaging techniques offer great opportunities for
detailed cardiovascular measurements in epidemiological
research. Thereby, subtle developmental cardiovascular
changes can be identified already in fetal or early postnatal
life. Furthermore, focusing on other biomarkers of cardiac
development, including detailed repeated measurements of
right cardiac structures, may give newer inside in the path-
way leading to the development of cardiovascular disease.
Although there is limited direct evidence that risk fac-
tors measured in childhood are predictive of atherosclerosis
in adulthood [116, 117], less is known about the associa-
tions of fetal and maternal factors during pregnancy and
vascular changes in childhood. Endothelial function and
structural arterial changes, including arterial resistance and
arterial stiffness, can be measured noninvasively en early
childhood with high resolution ultrasound to measure
brachial artery flow-mediated dilatation and carotid artery
intima-media thickness, respectively [148, 149]. Further-
more, future studies should focus on additional markers of
vascular structures and function, including retinal arteriolar
narrowing. This may lead to peripheral vascular resistance
and thereby predispose a person to the development of
hypertension and cardiovascular disease [150].
Clinical implications and future research
The associations between low birth weight and cardiovas-
cular disease in later life seem to be one of the most
intriguing and controversial epidemiological findings from
Early influences on cardiovascular and renal development 685
123
the last decade and might have clinical and public health
implications. However, the effect size of low birth weight on
cardiovascular disease and blood pressure in adulthood
presented in current studies seems to be small [1, 151].
Furthermore, the specific adverse exposures and underlying
mechanisms are not known. Recently, new areas of research
in cardiovascular epidemiology have already become
prominent. The focus has increasingly been on genes
implicated in cardiovascular diseases [152–156]. However,
the focus of most of the studies in cardiovascular epidemi-
ology is still on putative risk factors [157–165], with par-
ticular focus on nutrition [166–169], on socio-economic
factors and health inequalities [170–185], and, more
recently, on physical activity [186–189]. In addition, studies
focus on methods of cardiovascular studies [190–195] and
on frequency measures and trends in risks of cardiovascular
morbidity and mortality [196–205]. For further exploring
the underlying mechanisms and to assess potentials for
clinical implications, research has to move onwards from
birth weight association studies to adverse fetal exposures
and detailed early cardiovascular development studies.
Since plasticity operates across the entire range of envi-
ronment and leads to multigenerational cycles of disease,
any rational approach to health care should start early in life
and take a cross-generational perspective [206]. Data of
prospective cohort studies confirm the existence of a win-
dow of opportunity for intervention in early childhood [207,
208]. The growing awareness of the importance of the
preconceptual period, when nutrition can have long-lasting
effects without causing any change in birth weight, under-
scores the importance of healthy nutrition during the prep-
regnancy period. Research should also focus on identifying
individuals at greater risk of later poor health and develop
strategies aimed at these specific individuals.
Conclusion
The associations between low birth weigh and cardiovas-
cular disease are present within the normal and physiologic
ranges, and suggest that specific exposures in different
periods of fetal and early postnatal life have permanent
consequences for cardiovascular growth and function. The
mechanisms underlying these associations are not known,
but may include environmental and genetic determinants.
Future studies should be focused on these mechanisms and
epigenetic modifications of specific genes related to car-
diovascular development. Furthermore, studies should
focus on detailed cardiovascular adaptive responses in fetal
life and early childhood by use of new imaging and func-
tional techniques. Eventually results from these studies
may lead to improved health in childhood and adulthood by
promoting a better fetal environment.
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